Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
D. Timmerman(Rega Institute for Medical Research), L. Valentin(Malmö University), A. C. Testa(Università Cattolica del Sacro Cuore), E. Epstein(Karolinska Institutet), D. Fischerová(Charles University), T. Bourne(Luigi Sacco Hospital), L. Savelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Sabine Van Huffel(KU Leuven), Andrea Alberto Lissoni(University of Milano-Bicocca), Ignace Vergote(KU Leuven), Robert Fruscio(Azienda Ospedaliera San Gerardo), Lieveke Ameye(KU Leuven), G. B. Melis(University of Cagliari), Jenny Veldman(Utrecht University), C. Van Holsbeke(Ziekenhuis Oost-Limburg), S. Guerriero(University of Cagliari)
Cited by 473
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group
|Ultrasound in Obstetrics and Gynecology|2015|726